Evaluation of a colorimetric micromethod for determining the minimal inhibitory concentration of antibiotics against Mycobacterium tuberculosis;Evaluación de un micrométodo colorimétrico para determinar la concentración inhibitoria mínima de drogas antituberculosas frente a Mycobacterium tuberculosis

Revista Argentina de Microbiologia

Volumn 38, Issue 3, 2006, Pages 145-151

  Pontino, M V ^a   Di Giullo, B ^b   Fernandez C ^a   Imperiale, B ^a   Bodon, A ^a   Morcillo, N ^a  

^a Hospital Zonal de Agudos y Cronicos Dr Antonio A Cetrangolo   (Argentina)

^b Hospital Petrona V de Cordero   (Argentina)

Author keywords

First line drugs; Microplate colorimetric based method; Minimal inhibitory concentration; Multidrug resistant tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; BACTERIAL GROWTH; BACTERIUM DETECTION; COLORIMETRY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; ROC CURVE; SANITATION;

ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS;

EID: 33750946014     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Abate G, Aseffa A, Selassie A, Goshu S, Fekade B, Wolde Meskal D, et al. Direct colorimetric assay for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J Clin Microbiol 2004; 42: 871-3.
2. Ashok R, Awdhesh K, Nishat A. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. Emerg Infect Dis National Center for Infectious Diseases. Centers for Disease Control and Prevention, 1998, Atlanta, USA.
3. Banfi E, Scialino G, Monti-Bragadin C. Development of a microdilution method to evaluate Mycobacterium tuberculosis drug susceptibility. J Antimicrob Chemother 2003; 52: 796-800.
4. Barrera L. La tuberculosis vista con el lente de aproximación de la Biología Molecular. Medicina 2000; 60: 17-25.
5. Brunello F, Favari F, Fontana R. Comparison of MB/Bact T and BACTEC 460 TB systems for recovery of Mycobacteria from various clinical specimens. J Clin Microbiol 1999; 37: 1206-9.
6. Canetti G, Fox W, Khomenko A, Mahler HT, Menan NK, Mitchinson DA, et al. Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programs. Bull World Health Organization 1969; 41: 21-43.
7. Collins LA, Franzblau SG. Micro plate alamar blue assay versus Bactec460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and M. avium. Int J Tuberc Lung Dis 1997; 41: 1004-9.
8. De Logu A, Uda P, Pellerano ML. Comparison of two rapid colorimetric methods for determining resistance of Mycobacterium tuberculosis to rifampin, isoniazid and streptomycin in liquid medium. Eur J Clin Microbiol Infect Dis 2001; 20: 33-9.
9. Ellner JJ, Hinman AR, Dooley SW, Fishl MA, Sepkowitz KA, Golberger MJ, et al. Tuberculosis symposium: emerging problems and promise. J Infect Dis 1993; 168: 537-51.
10. Foongladda S, Roengsanthia D, Arjrattanakool W, Chuchottawom C, Chaiprasert A, Franzblau SG, et al. Rapid and simple MTT method for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2002; 6: 1118-22.
11. Goods GL. Susceptibility testing for mycobacteria. Clin Infect Dis 2000; 29: 1209-15.
12. Hanna B, Ebramhimzadeh A, Elliott B, Morgan M, Novak S, Rush-Gerdes S, et al. Multicenter evaluation of the Bactec MGIT 960 system for recovery of mycobacteria. J Clin Microbiol 1999; 37: 748-52.
13. Heifets LB. Conventional methods for antimicrobial susceptibility testing of M. tuberculosis. En: Bastian I, Portaels F, editors. Multidrug-resistant tuberculosis. London, Kluwer Academic Publishers, 2001, p. 135-6.
14. Herrera D, Cano R, Godoy P, Peiro EF, Castell J, Ibáñez C, et al. Multidrug-resistant tuberculosis outbreak on an HIV-ward - Madrid, Spain, 1991-1995. Morb Mortal Wkly Rep 1996; 45: 330-3.
15. Ken PT, Kubica GP. Public Health Mycobacteriology. A guide for the level III Laboratory. U.S. Department of Health and Human Services, Centers for Disease Control. Atlanta, USA, 1985.
16. Lemus D, Martín A, Montoro E, Portaels F, Palomino JC. Rapid alternative methods for detection of rifampicin resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 2004; 54: 130-3.
17. Martin A, Morcillo N, Lemus D, Montoro E, Da Silva Telles MA, Simboli N, et al. Multicenter study of MTT and resazurin assays for testing susceptibility to first-line anti-tuberculosis drugs. Int J Tuberc Lung Dis 2005; 9: 901-6.
18. McNeil BJ, Hanley JA. Statistical approaches to the analysis of receiver operating characteristic (ROC) curves. Med Decis Making 1984; 4: 137-50.
19. Montoro E, Lemus D, Echemendia M, Martín A, Portaels F, Palomino JC. Comparative evaluation of nitrate reduction assay, the MTT test and resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis. J Antimicrob Chemother 2005; 55: 500-5.
20. Morcillo N, Zumárraga M, Alito A, Dolmann A, Schouls L, Cataldi A. A low cost, home-made, reverse-line blot hybridisation assay for rapid detection of rifampin resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2002; 6: 959-65.
21. Morcillo N, Di Giulio B, Testani B, Pontino M, Chirico C, Dolmann A. A microplate indicator based method for determining the multidrug-resistant Mycobacterium tuberculosis to antimicrobial agents. Int Tuberc Lung Dis 2004; 8: 253-9.
22. Mshana RN, Tadesse G, Abate G, Miorner H. Use of 3-(4,5-dimethylthiazol- 2-y1)2,5-diphenyl tetrazolium bromide for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J Clin Microbiol 1998; 36: 1214-9.
23. Palomino JC. Novel rapid antimicrobial susceptibility test for Mycobacterium tuberculosis. En: Bastian I, Portaels F, editors. Multidrug-resistant tuberculosis. The Netherlands, Kluwer Academic Publishers, 2000, p. 152-4.
24. Palomino JC, Traore H, Fissette K, Portaels F. Evaluation of mycobacteria growth indicator tube (MGIT) for drug susceptibility testing of Mycobacterium tuberculosis. Inter J Tuberc Lung Dis 1999; 3: 344-8.
25. Ritacco V, Di Lonardo M, Reniero A, Ambroggi M, Barrera L, Dambrosi A, et al. Nosocomial spread of human immunodeficiency virus related multidrug-resistant tuberculosis in Buenos Aires. J Clin Infect Dis 1997; 176: 167-72.
26. Roberts GD, Goodman NL, Heifets L, Larsh HW, Lindner TH, Mc Clatchy JK, et al. Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J Clin Microbiol 1988; 15: 689-96.
27. Rossau R, Traore H, De Beenhouwer H, Mijs W, Jannes G, De Rijk P, et al. Evaluation of the INNO-LIPA Rif TB assays a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob Agents Chemother 1997; 41: 2093-8.
28. Thom SM, Horobin RW, Seidler E, Barrer MR. Factors affecting the selection and use of tetrazolium salts as cytochemical indicators of microbial viability and activity. J Appl Bacteriol 1993; 74: 433-43.
29. Toman K. Sensitivity, specificity and predictive values of diagnostic tests. Bull Int Union Tuberc 1981; 56: 18-30.
30. United Nations University (UNV) and Latin American and the Caribbean Network of tuberculosis (RELACTB). New technologies for diagnosis and drug-susceptibility testing of M. tuberculosis for developing countries. Institute of National Laboratories of Health (INLASA). La Paz, Bolivia, 1998, p.24-32.
31. Van Der Schouw IT, Verbeek AIM, Ruijs SHJ. Guidelines for the assessment of new diagnostic tests. Investigative Radiology 1995; 30: 334-40.
32. Wilson SM, Suwiadi ZA, Mc Nerney R, Porter J, Drobniewski F. Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis. Nat Med 1997; 4: 465-8.
33. World Health Organization. The containment laboratory biosafety level III. Laboratory biosafety manual, Second edition. Geneva, Switzerland, 1993, p. 19-23.
34. o 2. Prevalence and Trends. (WHO/ CDC/TB/00.278) 2000, Geneva.
35. Yajko D, Madej J, Lancaster MV, Sanders CA, Cawthon VL, Gee B, et al. Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis. J Clin Microbiol 1995; 33: 2324-7.
36. Badak FZ, Goksel S, Sertoz R, Nafile B, Ermertcan S, Cavusoglu C, et al. Use of nucleic acid probes for identification of Mycobacterium tuberculosis directly from MB/ BacT bottles. J Clin Microbiol 1999; 37: 1602-5.